Posted by Michael Wonder on 29 Nov 2018
Merck raised prices five drugs including Keytruda in November
28 November 2018 - Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5% and 6%, including its top-selling cancer treatment Keytruda.
The list price increases are the first that the U.S. drugmaker has made since pledging in July that it would not raise the average net price of all of its medicines by more than the inflation rate.
Merck raised the price of cancer immunotherapy Keytruda, which is forecast to bring in more than $7 billion in sales this year, by around 1.5%.
